The use of inductively coupled plasma mass spectrometry as a detector in drug metabolism studies

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Expert Opinion on Drug Metabolism & Toxicology

• Publication date

  2008-08-24

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1517/17425255.4.9.1187
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Heteroatom(isotope)-tagged proteomics via ICP-MS: screening and quantification of proteins and their post-translational modifications

  2008cited by this paper
• Analytical artefacts in the speciation of arsenic in clinical samples.

  2008influential reference
• Study of tungstate–protein interaction in human serum by LC–ICP-MS and MALDI-TOF

  2008cited by this paper
• Handbook of Drug Metabolism

  2008cited by this paper
• Use of the bromine isotope ratio in HPLC-ICP-MS and HPLC-ESI-MS analysis of a new drug in development

  2008cited by this paper
• ICP-MS as a new tool for the determination of gold nanoparticles in bioanalytical applications

  2008cited by this paper
• Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents.

  2008influential reference
• The application of inductively coupled plasma mass spectrometry in clinical pharmacological oncology research.

  2008cited by this paper
• Design and evaluation of a multi-detection system composed of ultraviolet, evaporative light scattering and inductively coupled plasma mass spectrometry detection for the analysis of pharmaceuticals by liquid chromatography.

  2008cited by this paper
• Isolation, structural elucidation and characterization of impurities in Cefdinir.

  2007cited by this paper
• SEC-ICP-MS and ESI-MS as tools to study the interaction between cisplatin and cytosolic biomolecules

  2007cited by this paper
• An inductively coupled plasma mass spectrometry method for the quantification of yttrium-antibody based drugs using stable isotope tracing.

  2007cited by this paper
• Application of inductively coupled plasma mass spectrometry in drug metabolism studies

  2007cited by this paper
• Metal based drugs: from serendipity to design.

  2007influential reference
• Hyphenation of reverse-phase HPLC and ICP-MS for metabolite profiling—application to a novel antituberculosis compound as a case study

  2007cited by this paper
• Iodine speciation in human serum by reversed-phase liquid chromatography-ICP-mass spectrometry

  2007cited by this paper
• Speciation analysis of platinum antitumoral drugs in impacted tissues.

  2007cited by this paper
• Biochemical mechanisms of cisplatin cytotoxicity.

  2007influential reference
• Metabolism of 2-fluoro-4-iodoaniline in earthworm Eisenia veneta using 19F-NMR spectroscopy, HPLC-MS, and HPLC-ICPMS (127I)

  2007cited by this paper
• A study of the interactions between carboplatin and blood plasma proteins using size exclusion chromatography coupled to inductively coupled plasma mass spectrometry

  2007cited by this paper
• The role of sulfur in platinum anticancer chemotherapy.

  2007cited by this paper
• Probing the stability of serum protein–ruthenium(III) drug adducts in the presence of extracellular reductants using CE

  2007cited by this paper
• Method developments for iodine speciation by reversed-phase liquid chromatography-ICP-mass spectrometry

  2007cited by this paper
• Metabolism of [14C]-5-chloro-1,3-benzodioxol-4-amine in male Wistar-derived rats following intraperitoneal administration

  2007cited by this paper
• Determination of Active Pharmaceutical Ingredients by Heteroatom Selective Detection Using Inductively Coupled Plasma Mass Spectrometry with Ultrasonic Nebuilization and Membrane Desolvation Sample Introduction

  2006cited by this paper
• The role of cisplatin and NAMI-A plasma-protein interactions in relation to combination therapy.

  2006cited by this paper
• Validation and use of three complementary analytical methods (LC–FLS, LC–MS/MS and ICP–MS) to evaluate the pharmacokinetics, biodistribution and stability of motexafin gadolinium in plasma and tissues

  2006cited by this paper
• Metabolism of 3-chloro-4-fluoroaniline in rat using [14C]-radiolabelling, 19F-NMR spectroscopy, HPLC-MS/MS, HPLC-ICPMS and HPLC-NMR

  2006influential reference
• Biotech blockbusters consolidate markets

  2006cited by this paper
• Platinum group metallodrug‐protein binding studies by capillary electrophoresis – inductively coupled plasma‐mass spectrometry: A further insight into the reactivity of a novel antitumor ruthenium(III) complex toward human serum proteins

  2006cited by this paper
• Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology.

  2006influential reference
• Direct comparison of capillary electrophoresis and capillary liquid chromatography hyphenated to collision-cell inductively coupled plasma mass spectrometry for the investigation of Cd-, Cu- and Zn-containing metalloproteins.

  2006cited by this paper
• Down-scaling narrowbore LC-ICP-MS to capillary LC-ICP-MS: a comparative study of different introduction systems

  2006cited by this paper
• The application of inductively coupled plasma mass spectrometry in pharmaceutical and biomedical analysis.

  2006cited by this paper
• Study of bradykinin metabolism by rat lung tissue membranes and rat kidney brush border membranes by HPLC with inductively coupled plasma—mass spectrometry and orthogonal acceleration time‐of‐flight mass spectrometry

  2006cited by this paper
• Specific determination of intact cisplatin and monohydrated cisplatin in human plasma and culture medium ultrafiltrates using HPLC on-line with inductively coupled plasma mass spectrometry.

  2006cited by this paper
• Two dimensional separation schemes for investigation of the interaction of an anticancer ruthenium(III) compound with plasma proteins

  2005influential reference
• ICP-MS for specific detection in capillary electrophoresis

  2005cited by this paper
• Investigation of the metabolic fate of 2-, 3- and 4-bromobenzoic acids in bile-duct-cannulated rats by inductively coupled plasma mass spectrometry and high-performance liquid chromatography/inductively coupled plasma mass spectrometry/electrospray mass spectrometry.

  2005cited by this paper
• Interactions of a novel ruthenium-based anticancer drug (KP1019 or FFC14a) with serum proteins--significance for the patient.

  2005cited by this paper
• Application of CE–ICP–MS and CE–ESI–MS in metalloproteomics: challenges, developments, and limitations

  2005cited by this paper
• Intact human holo-transferrin interaction with oxaliplatin.

  2005cited by this paper
• High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies.

  2005cited by this paper
• Complementary FPLC-ICP-MS and MALDI-TOF for studying vanadium association to human serum proteins

  2005cited by this paper
• HPLC-ICP-MS compared with radiochemical detection for metabolite profiling of 3H-bromohexine in rat urine and faeces

  2005cited by this paper
• Volatile organic solvent-induced signal enhancements in inductively coupled plasma-mass spectrometry: a case study of methanol and acetone

  2004cited by this paper
• SEC-ICP-DRCMS and SEC-ICP-SFMS for determination of metal–sulfur ratios in metalloproteins

  2004cited by this paper
• Sensitive sulphur-specific detection of omeprazole metabolites in rat urine by high-performance liquid chromatography/inductively coupled plasma mass spectrometry.

  2004cited by this paper
• Collision and reaction cells in atomic mass spectrometry: development, status, and applications

  2004cited by this paper
• Investigation of the reaction of cisplatin with methionine in aqueous media using HPLC-ICP-DRCMS

  2004cited by this paper
• Platinum metallodrug‐protein binding studies by capillary electrophoresis‐inductively coupled plasma‐mass spectrometry: Characterization of interactions between Pt(II) complexes and human serum albumin

  2004cited by this paper
• Binding patterns of vanadium to transferrin in healthy human serum studied with HPLC/high resolution ICP-MS.

  2004cited by this paper
• Enhanced Detection of Sulphur and Phospho-rous Containing Compounds in HPLC-Induc-tively Coupled Plasma Mass Spectrometry Using Chemical Resolution via Hexapole-Based Reaction with Oxygen

  2004cited by this paper
• Determination of 2,4,6-triiodophenol and its metabolites in human urine by anion-exchange chromatography with ICP-MS detection

  2004cited by this paper
• Determination of levothyroxine and its degradation products in pharmaceutical tablets by HPLC-UV-ICP-MS

  2004cited by this paper
• Interaction of oxaliplatin, cisplatin, and carboplatin with hemoglobin and the resulting release of a heme group.

  2004cited by this paper
• Application of inductively coupled plasma mass spectrometry and high-performance liquid chromatography--with parallel electrospray mass spectrometry to the investigation of the disposition and metabolic fate of 2-, 3- and 4-iodobenzoic acids in the rat.

  2004cited by this paper
• Optimisation of ICP-dynamic reaction cell-MS as specific detector for the speciation analysis of vanadium at therapeutic levels in serum

  2003cited by this paper
• Sensitive species-specific monitoring of a new triplatinum anti-cancer drug and its potential related compounds in spiked human plasma by cation-exchange HPLC-ICP-MS

  2003cited by this paper
• Mass spectrometric studies of cisplatin-induced changes of hemoglobin.

  2003cited by this paper
• Direct evidence for co-binding of cisplatin and cadmium to a native zinc- and cadmium-containing metallothionein

  2003cited by this paper
• Application of HPLC-ICP-MS to speciation of cisplatin and its degradation products in water containing different chloride concentrations and in human urine

  2003cited by this paper
• High-performance liquid chromatography/inductively coupled plasma mass spectrometry with iodine-specific detection for profiling the metabolites produced in the earthworm Eisenia veneta by exposure to 2-fluoro-4-iodoaniline.

  2003cited by this paper
• Binding of bismuth to serum proteins: implication for targets of Bi(III) in blood plasma.

  2003cited by this paper
• A comparison of the quantitative methods for the analysis of the platinum-containing anticancer drug [cis-[amminedichloro(2-methylpyridine)]platinum(II)] (ZD0473) by HPLC coupled to either a triple quadrupole mass spectrometer or an inductively coupled plasma mass spectrometer.

  2003cited by this paper
• Determination of sulfur and selected trace elements in metallothionein-like proteins using capillary electrophoresis hyphenated to inductively coupled plasma mass spectrometry with an octopole reaction cell

  2003cited by this paper
• Comparison of direct injection nebulizer and desolvating microconcentric nebulizer for analysis of chlorine-, bromine- and iodine-containing compounds by reversed phase HPLC with ICP-MS detection

  2003cited by this paper
• High-performance liquid chromatography-UV diode array, inductively coupled plasma mass spectrometry (ICMPS) and orthogonal acceleration time-of-flight mass spectrometry (oa-TOFMS) applied to the simultaneous detection and identification of metabolites of 4-bromoaniline in rat urine

  2002cited by this paper
• Rapid biotransformation of satraplatin by human red blood cells in vitro

  2002cited by this paper
• Modified direct injection high efficiency nebulizer with minimized dead volume for the analysis of biological samples by micro- and nano-LC-ICP-MS

  2002cited by this paper
• Analysis of a [14C]-labelled platinum anticancer compound in dosing formulations and urine using a combination of HPLC-ICPMS and flow scintillation counting

  2002influential reference
• Study of bradykinin metabolism in human and rat plasma by liquid chromatography with inductively coupled plasma mass spectrometry and orthogonal acceleration time-of-flight mass spectrometry.

  2002cited by this paper
• Quantitation in gradient high performance liquid chromatography/inductively coupled mass spectrometry investigated using diclofenac and chlorpromazine.

  2002cited by this paper
• Monitoring of total antimony and its species by ICP-MS and on-line ion chromatography in biological samples from patients treated for leishmaniasis

  2002influential reference
• HPIC–UV–ICP–SFMS study of the interaction of cisplatin with guanosine monophosphate

  2001influential reference
• Protein phosphorylation degree: determination by capillary liquid chromatography and inductively coupled plasma mass spectrometry.

  2001cited by this paper
• The potential of inductively coupled plasma mass spectrometry detection for high-performance liquid chromatography combined with accurate mass measurement of organic pharmaceutical compounds.

  2001cited by this paper
• Chemical instability and methods for measurement of cisplatin adducts formed by interactions with cysteine and glutathione.

  2001cited by this paper
• High-performance liquid chromatography linked to inductively coupled plasma mass spectrometry and orthogonal acceleration time-of-flight mass spectrometry for the simultaneous detection and identification of metabolites of 2-bromo-4-trifluoromethyl.

  2001cited by this paper
• Sulfur-specific detection of impurities in cimetidine drug substance using liquid chromatography coupled to high resolution inductively coupled plasma mass spectrometry and electrospray mass spectrometry.

  2001cited by this paper
• Early biotransformations of oxaliplatin after its intravenous administration to cancer patients.

  2000cited by this paper
• High-performance liquid chromatography and inductively coupled plasma mass spectrometry (HPLC-ICP-MS) for the analysis of xenobiotic metabolites in rat urine: application to the metabolites of 4-bromoaniline.

  2000cited by this paper
• Directly coupled liquid chromatography with inductively coupled plasma mass spectrometry and orthogonal acceleration time-of-flight mass spectrometry for the identification of drug metabolites in urine: application to diclofenac using chlorine and sulfur detection.

  2000cited by this paper
• Investigation of metallodrug–protein interactions by size-exclusion chromatography coupled with inductively coupled plasma mass spectrometry (ICP-MS)

  1999cited by this paper
• Quantitative structure-metabolism relationships (QSMR) using computational chemistry: pattern recognition analysis and statistical prediction of phase II conjugation reactions of substituted benzoic acids in the rat.

  1999cited by this paper
• Quantitative determination of platinum complexes in human plasma generated from the oral antitumour drug JM216 using directly coupled high-performance liquid chromatography-inductively coupled plasma mass spectrometry without desolvation

  1999cited by this paper
• Determination of sulfur isotope ratios and concentrations in water samples using ICP-MS incorporating hexapole ion optics

  1999cited by this paper
• A Table of Polyatomic Interferences in ICP-MS

  1998cited by this paper
• Sector field mass spectrometers in ICP-MS

  1998cited by this paper
• Kinetic studies of the reactivity between cisplatin and its monoaquo species with L-methionine

  1998cited by this paper
• A high performance liquid chromatography – inductively coupled plasma-mass spectrometry interface employing desolvation for speciation studies of platinum in chemotherapy drugs

  1996cited by this paper
• Inductively coupled and microwave induced plasma sources for mass spectrometry

  1995cited by this paper
• GOLD BINDING SITES IN RED BLOOD CELLS

  1995cited by this paper
• Development of an HPLC–ICP–MS method for the determination of platinum species from new anti-tumour drugs

  1994cited by this paper
• Speciation of iodo amino acids by high-performance liquid chromatography with inductively coupled plasma mass spectrometric detection

  1993cited by this paper
• Dicyanogold (I) is a common human metabolite of different gold drugs.

  1993cited by this paper
• Determination of cisplatin and some possible metabolites by ion-pairing chromatography with inductively coupled plasma mass spectrometric detection.

  1993cited by this paper
• Determination of gold-based antiarthritis drugs and their metabolites in urine by reversed-phase ion-pair chromatography with ICP-MS detection.

  1992influential reference
• Handbook of Inductively Coupled Plasma Mass Spectrometry

  1991cited by this paper
• Goodman and Gilman's The Pharmacological Basis of Therapeutics

  1991cited by this paper

• Quantitative analysis of related substances in acetaminophen tablets using pre-column derivatization coupled with HPLC–ICP-MS

  2025cites this paper
• Liquid Chromatography with Dual Mass Spectrometry Detection: An Approach to the Determination of Br-Containing Disinfection By-Products in Drinking Water

  2025cites this paper
• Inductively Coupled Plasma Mass Spectroscopy: A Comprehensive Review of Principles, Instrumentation, Analytical Procedures, and Pharmaceutical Applications

  2025cites this paper
• Quantification of oxaliplatin- and ioversol-related compounds in pharmaceutical formulations using novel HPLC-ICP-MS methods.

  2024cites this paper
• Half-life determination of inorganic-organic hybrid nanomaterials in mice using laser-induced breakdown spectroscopy

  2020cites this paper
• The impact of whole human blood on the kinetic inertness of platinum(iv) prodrugs – an HPLC-ICP-MS study

  2018cites this paper
• A pre-column derivatization method allowing quantitative metabolite profiling of carboxyl and phenolic hydroxyl group containing pharmaceuticals in human plasma via liquid chromatography-inductively coupled plasma-tandem mass spectrometry (LC-ICP-MS/MS)

  2018cites this paper
• High-performance liquid chromatography coupled to inductively coupled plasma – Mass spectrometry (HPLC-ICP-MS) for quantitative metabolite profiling of non-metal drugs

  2017cites this paper
• UNDERSTANDING DRUG METABOLISM IN HUMANS

  2016cites this paper
• Elemental bioimaging of Cisplatin in Caenorhabditis elegans by LA-ICP-MS.

  2015cites this paper
• Selective ruthenium labeling of the tryptophan residue in the bee venom Peptide melittin.

  2015cites this paper
• Complementarity of MALDI and LA ICP mass spectrometry for platinum anticancer imaging in human tumor.

  2014cites this paper
• A Nonradioactive Approach to Investigate the Metabolism of Therapeutic Peptides by Tagging with 127I and Using Inductively-Coupled Plasma Mass Spectrometry Analysis

  2014cites this paper
• Anwendung der Platinspeziation zum Nachweis einer Aktivierung oder Inhibierung von Pt enthaltenden Krebsmedikamenten

  2014cites this paper
• Recent progress of ICP-MS in the development of metal-based drugs and diagnostic agents

  2014cites this paper
• Inductively coupled plasma mass spectrometry for metallodrug development: albumin binding and serum distribution of cytotoxic cis- and trans-isomeric platinum(II) complexes.

  2014cites this paper
• Quantitative determination of platinum derived from cisplatin in human plasma ultrafiltrate using derivatization with diethyldithiocarbamate and liquid chromatography coupled with electrospray ionization tandem mass spectrometry

  2013cites this paper
• Metallomics for drug development: serum protein binding and analysis of an anticancer tris(8-quinolinolato)gallium(III) drug using inductively coupled plasma mass spectrometry.

  2013cites this paper
• In vitro studies on cisplatin focusing on kinetic aspects of intracellular chemistry by LC-ICP-MS.

  2013cites this paper
• Overview of the Various Types of Mass Spectrometers that are Used in Drug Discovery and Drug Development

  2013cites this paper
• Determination of platinum drug release and liposome stability in human plasma by CE-ICP-MS.

  2013cites this paper
• Hyphenated techniques as tools for speciation analysis of metal-based pharmaceuticals: developments and applications

  2012cites this paper
• Determination of S-containing drug metabolites from in vitro and in vivo metabolism studies by using LC-ICP/MS

  2012cites this paper
• Use of relative 12C/14C isotope ratios to estimate metabolite concentrations in the absence of authentic standards.

  2012cites this paper
• Electrochemistry coupled to (liquid chromatography/) mass spectrometry--current state and future perspectives.

  2012cites this paper
• Inductively coupled plasma-MS in drug development: bioanalytical aspects and applications.

  2012cites this paper
• HPLC/ICP-MS in combination with "reverse" online isotope dilution in drug metabolism studies.

  2012cites this paper
• Approaches for the rapid identification of drug metabolites in early clinical studies.

  2011cites this paper
• Determination of gallium originated from a gallium-based anticancer drug in human urine using ICP-MS

  2011cites this paper
• Speciation analysis of bromine-containing drug metabolites in feces samples from a human in vivo study by means of HPLC/ICP-MS combined with on-line isotope dilution

  2011cites this paper
• Quantitative determination of intact free cisplatin in cell models by LC-ICP-MS

  2011cites this paper
• High temperature liquid chromatography hyphenated with ESI-MS and ICP-MS detection for the structural characterization and quantification of halogen containing drug metabolites.

  2011cites this paper
• Recent progress in the application of analytical techniques to anticancer metallodrug proteomics

  2011cites this paper
• Inductively-Coupled Plasma Mass Spectrometry in Proteomics, Metabolomics and Metallomics Studies

  2010cites this paper
• A comparison between HPLC-dynamic reaction cell-ICP-MS and HPLC-sector field-ICP-MS for the detection of glutathione-trapped reactive drug metabolites using clozapine as a model compound

  2010cites this paper
• Analytical Tools and Approaches for Metabolite Identification in Drug Metabolism

  2010cites this paper
• Platinum speciation used for elucidating activation or inhibition of Pt-containing anti-cancer drugs.

  2010cites this paper
• On-line fast column switching SEC × IC separation combined with ICP-MS detection for mapping metallodrug–biomolecule interaction

  2010cites this paper
• Looking back through the MIST: a perspective of evolving strategies and key focus areas for metabolite safety analysis.

  2010cites this paper
• Metabolite quantitation: detector technology and MIST implications.

  2009cites this paper
• Quantification of cisplatin, carboplatin and oxaliplatin in spiked human plasma samples by ICP-SFMS and hydrophilic interaction liquid chromatography (HILIC) combined with ICP-MS detection

  2009cites this paper
• Comparison of two CE-ICP-MS interfaces and quantitative measurements of carboplatin in plasma samples using an internal standard

  2009cites this paper